Scaling-up recombinant plasmid DNA for clinical trial: Current concern, solution and status

► Safety concern on the genetic elements of plasmid DNA for clinical usage. ► Host genomic modification for the production of safer plasmid DNA. ► Alternative selection system to antibiotic resistance marker. ► Recent patent and development lead to safe and cost effective plasmid DNA production.